These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36594679)

  • 1. Impact of solute carrier transporter gene polymorphisms on serum creatinine concentrations in healthy volunteers.
    Yokoyama S; Nakagawa J; Kudo M; Aiuchi N; Seito T; Isida M; Mikami T; Ihara K; Nakaji S; Niioka T
    Pharmacol Res Perspect; 2023 Feb; 11(1):e01048. PubMed ID: 36594679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.
    Raj GM; Mathaiyan J; Wyawahare M; Priyadarshini R
    Drug Metab Pers Ther; 2018 Dec; 33(4):175-185. PubMed ID: 30433870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of
    Chen P; Cao Y; Chen S; Liu Z; Chen S; Guo Y
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic identification and characterization of cynomolgus macaque solute carrier transporters.
    Uno Y; Yamazaki H
    Drug Metab Pharmacokinet; 2022 Apr; 43():100437. PubMed ID: 35081498
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Anderson LL; Etchart MG; MacNair L; Land MH; Mosesova IA; Bonn-Miller MO; Arnold JC
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):304-317. PubMed ID: 33998860
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events.
    Iwata K; Aizawa K; Kamitsu S; Jingami S; Fukunaga E; Yoshida M; Yoshimura M; Hamada A; Saito H
    Clin Exp Nephrol; 2012 Dec; 16(6):843-51. PubMed ID: 22569819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
    Yokoyama S; Nakagawa J; Aiuchi N; Seito T; Niioka T
    J Clin Pharm Ther; 2022 Sep; 47(9):1409-1417. PubMed ID: 35545234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy.
    Abumiya M; Takahashi N; Takahashi S; Yoshioka T; Kameoka Y; Miura M
    Sci Rep; 2021 Mar; 11(1):6362. PubMed ID: 33737618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic landscape of the human solute carrier (SLC) transporter superfamily.
    Schaller L; Lauschke VM
    Hum Genet; 2019 Dec; 138(11-12):1359-1377. PubMed ID: 31679053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer.
    Bendova P; Pardini B; Susova S; Rosendorf J; Levy M; Skrobanek P; Buchler T; Kral J; Liska V; Vodickova L; Landi S; Soucek P; Naccarati A; Vodicka P; Vymetalkova V
    Carcinogenesis; 2021 Apr; 42(3):378-394. PubMed ID: 33319241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of changes in serum creatinine and creatinine clearance caused by renal transporter inhibition in healthy subjects.
    Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):233-238. PubMed ID: 31176593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare mutations associating with serum creatinine and chronic kidney disease.
    Sveinbjornsson G; Mikaelsdottir E; Palsson R; Indridason OS; Holm H; Jonasdottir A; Helgason A; Sigurdsson S; Jonasdottir A; Sigurdsson A; Eyjolfsson GI; Sigurdardottir O; Magnusson OT; Kong A; Masson G; Sulem P; Olafsson I; Thorsteinsdottir U; Gudbjartsson DF; Stefansson K
    Hum Mol Genet; 2014 Dec; 23(25):6935-43. PubMed ID: 25082825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition.
    Nakada T; Kudo T; Ito K
    Drug Metab Dispos; 2023 Sep; 51(9):1114-1126. PubMed ID: 36859345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers.
    Saiz-Rodríguez M; Ochoa D; Zubiaur P; Navares-Gómez M; Román M; Camargo-Mamani P; Luquero-Bueno S; Villapalos-García G; Alcaraz R; Mejía-Abril G; Santos-Mazo E; Abad-Santos F
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine.
    Casado JL; Monsalvo M; Vizcarra P; Fontecha M; Serrano-Villar S; Moreno S
    HIV Med; 2019 Nov; 20(10):648-656. PubMed ID: 31321875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
    Daka A; Dimovski A; Kapedanovska A; Vavlukis M; Eftimov A; Labachevski N; Jakjovski K; Geshkovska MN; Nebija D; Mladenovska K
    Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in solute carrier genes (SLC19A1, SLCO1B1, and SLCO1B3) predicts survival and toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
    Sharma P; Singh N; Sharma S
    J Clin Pharm Ther; 2022 Dec; 47(12):2049-2067. PubMed ID: 35896189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of common polymorphisms of the farnesoid X receptor and bile acid transporters on the pharmacokinetics of ursodeoxycholic acid.
    Hu M; Fok BS; Wo SK; Lee VH; Zuo Z; Tomlinson B
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):34-40. PubMed ID: 26382575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of elevation of serum creatinine via renal transporter inhibition by trimethoprim in healthy subjects using physiologically-based pharmacokinetic model.
    Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):103-110. PubMed ID: 29361388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
    Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
    Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.